Corrigendum to "Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis" [Pharmacol. Res. 156 (June 2020) 104805].

Luo, Xialin; Liu, Jingjing; Wang, Huaizhi; Lu, Haitao

Luo, Xialin; Liu, Jingjing; Wang, Huaizhi; Lu, Haitao.

Afiliação

Luo X; Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China; Laboratory for Functional Metabolomics Science, Shanghai Jiao Tong University, Shanghai 200240, China.
Liu J; Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China; Laboratory for Functional Metabolomics Science, Shanghai Jiao Tong University, Shanghai 200240, China.
Wang H; Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing 401121, China.
Lu H; Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China; Laboratory for Functional Metabolomics Science, Shanghai Jiao Tong University, Shanghai 200240, China. Electronic address: haitao.lu@sjtu.edu

Pharmacol Res ; 169: 105657, 2021 Jul.

Article em En | MEDLINE | ID: mdl-34015705

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google